Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights

a week ago

FORT LEE, N.J., Nov. 05, 2024 ( GLOBE NEWSWIRE ) -- Nuvectis Pharma, Inc. ( NASDAQ: NVCT ) ( "Nuvectis" or the "Company" ) , a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in ...

Ticker	Sentiment	Impact
NVCT	Neutral	14 %